High-grade dysplasia in Barrett's esophagus is associated with increased expression of calgranulin A and B

References

• Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol 2002; 97: 1930–6
   PubMed Web of Science ®Google Scholar
• Falk GW. Barrett's esophagus. Gastroenterology 2002; 122: 1569–91
   PubMed Web of Science ®Google Scholar
• Hamilton SR, Smith RR. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987; 87: 301–12
   PubMed Web of Science ®Google Scholar
• Barrett MT, Sanchez CA, Prevo LJ, Wong DJ, Galipeau PC, Paulson TG, et al. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 1999; 22: 106–9
   PubMedGoogle Scholar
• Bax DA, Siersema PD, Van Vliet AH, Kuipers EJ, Kusters JG. Molecular alterations during development of esophageal adenocarcinoma. J Surg Oncol 2005; 92: 89–98
   PubMedGoogle Scholar
• Levine DS. Management of dysplasia in the columnar-lined esophagus. Gastroenterol Clin North Am 1997; 26: 613–34
   PubMedGoogle Scholar
• Hardwick RH, Shepherd NA, Moorghen M, Newcomb PV, Alderson D. Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence. Gut 1994; 35: 764–8
   PubMed Web of Science ®Google Scholar
• Bailey T, Biddlestone L, Shepherd N, Barr H, Warner P, Jankowski J. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. Am J Pathol 1998; 152: 135–44
   PubMed Web of Science ®Google Scholar
• Bax DA, Haringsma J, Einerhand AW, van Dekken H, Blok P, Siersema PD, et al. MUC4 is increased in high grade intraepithelial neoplasia in Barrett's oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio. J Clin Pathol 2004; 57: 1267–72
   PubMed Web of Science ®Google Scholar
• Moons LM, Kusters JG, Bultman E, Kuipers EJ, van Dekken H, Tra WM, et al. Barrett's oesophagus is characterized by a predominantly humoral inflammatory response. J Pathol 2005; 207: 269–76
   PubMed Web of Science ®Google Scholar
• Cross SS, Hamdy FC, Deloulme JC, Rehman I. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 2005; 46: 256–69
   PubMed Web of Science ®Google Scholar
• Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Mod Pathol 2001; 14: 397–403
   PubMedGoogle Scholar
• Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 2003; 170: 3233–42
   PubMed Web of Science ®Google Scholar
• Vandal K, Rouleau P, Boivin A, Ryckman C, Talbot M, Tessier PA. Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J Immunol 2003; 171: 2602–9
   PubMed Web of Science ®Google Scholar
• Kerkhoff C, Klempt M, Kaever V, Sorg C. The two calcium-binding proteins, S100A8 and S100A9, are involved in the metabolism of arachidonic acid in human neutrophils. J Biol Chem 1999; 274: 32672–9
   PubMedGoogle Scholar
• Broome AM, Ryan D, Eckert RL. S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem 2003; 51: 675–85
   PubMed Web of Science ®Google Scholar
• Thorey IS, Roth J, Regenbogen J, Halle JP, Bittner M, Vogl T, et al. The Ca2 + -binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes. J Biol Chem 2001; 276: 35818–25
   PubMed Web of Science ®Google Scholar
• Grimbaldeston MA, Geczy CL, Tedla N, Finlay-Jones JJ, Hart PH. S100A8 induction in keratinocytes by ultraviolet A irradiation is dependent on reactive oxygen intermediates. J Invest Dermatol 2003; 121: 1168–74
   PubMedGoogle Scholar
• Olyaee M, Sontag S, Salman W, Schnell T, Mobarhan S, Eiznhamer D, et al. Mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus. Gut 1995; 37: 168–73
   PubMed Web of Science ®Google Scholar
• Berthier S, Paclet MH, Lerouge S, Roux F, Vergnaud S, Coleman AW, et al. Changing the conformation state of cytochrome b558 initiates NADPH oxidase activation: MRP8/MRP14 regulation. J Biol Chem 2003; 278: 25499–508
   PubMed Web of Science ®Google Scholar
• Kerkhoff C, Nacken W, Benedyk M, Dagher MC, Sopalla C, Doussiere J. The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2. Faseb J 2005; 19: 467–9
   PubMed Web of Science ®Google Scholar
• Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000; 47: 506–13
   PubMed Web of Science ®Google Scholar
• El-Rifai W, Moskaluk CA, Abdrabbo MK, Harper J, Yoshida C, Riggins GJ, et al. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res 2002; 62: 6823–6
   PubMed Web of Science ®Google Scholar
• Chaurand P, DaGue BB, Pearsall RS, Threadgill DW, Caprioli RM. Profiling proteins from azoxymethane-induced colon tumors at the molecular level by matrix-assisted laser desorption/ionization mass spectrometry. Proteomics 2001; 1: 1320–6
   PubMed Web of Science ®Google Scholar
• van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 1999–2009
   PubMed Web of Science ®Google Scholar